Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
102.50B | 106.85B | 149.00B | 88.74B | 45.75B | Gross Profit |
41.93B | 48.04B | 88.81B | 41.87B | 9.53B | EBIT |
30.93B | 35.77B | 78.81B | 33.66B | -2.87B | EBITDA |
39.56B | 50.18B | 85.75B | 42.98B | 6.60B | Net Income Common Stockholders |
8.81B | 11.88B | 28.75B | 8.56B | -5.50B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
23.45B | 38.87B | 45.45B | 33.28B | 18.62B | Total Assets |
131.14B | 143.58B | 158.02B | 147.12B | 121.97B | Total Debt |
30.09B | 31.80B | 32.17B | 36.24B | 38.12B | Net Debt |
21.97B | 22.16B | 16.59B | 24.21B | 31.36B | Total Liabilities |
88.76B | 95.08B | 104.03B | 108.10B | 88.08B | Stockholders Equity |
42.34B | 48.49B | 53.99B | 39.01B | 33.87B |
Cash Flow | Free Cash Flow | |||
7.93B | 14.13B | 26.38B | 20.78B | 1.91B | Operating Cash Flow |
20.11B | 24.70B | 35.14B | 28.82B | 10.39B | Investing Cash Flow |
-3.53B | -12.41B | -15.86B | -16.21B | -12.09B | Financing Cash Flow |
-17.74B | -18.14B | -15.41B | -4.84B | 2.99B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $66.80B | 8.17 | 19.39% | 4.50% | -4.07% | -20.34% | |
79 Outperform | $191.04B | 12.55 | 8.82% | 4.33% | -5.74% | -11.09% | |
78 Outperform | $122.01B | 8.41 | 13.43% | 4.80% | -10.66% | -23.19% | |
77 Outperform | $45.60B | 16.67 | 5.58% | 5.18% | -5.16% | -41.74% | |
76 Outperform | $82.86B | 13.31 | 10.52% | 20.11% | -10.81% | -70.65% | |
61 Neutral | $81.31B | 219.47 | 0.59% | 6.54% | -9.97% | -98.08% | |
57 Neutral | $7.70B | 4.18 | -3.52% | 8.32% | 0.35% | -64.68% |